Stocks slumped on Thursday, leaving the Dow with only small gains for the month. Markets were under pressure following the latest signs of an economy merely limping along and as investors digested key earnings reports. Biotech stocks were the worst performers on the Nasdaq, led by Celgene (CELG) which missed quarterly revenue estimates. Chinese search engine Baidu (BIDU) was also lagging the Nasdaq after reporting its slowest quarterly sales growth in nearly 7 years. Apple (AAPL) weighed on the Dow and led losses among the tech sector. Viacom (VIAB) slid after swinging to a net loss in its second quarter.
More from Video
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.